Scancell Holdings Share News (SCLP)
SCLP Share
SCLP Share
SCLP Share
SCLP Share
SCLP
SCLP Share
SCLP Level 2
SCLP Live
SCLP Broker
SCLP Directors
SCLP Financial
SCLP
SCLP Short
SCLP
Last checked at -
(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell announced on Friday that the enrolment and treatment of the first patient had taken place in its multicentre phase 2 c...
Read more
IN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause...
Read moreUK shareholder meetings calendar - next 7 days...
Read moreDIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares...
Read moreIN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors...
Read moreTRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags...
Read moreUK earnings, trading statements calendar - next 7 days...
Read moreIN BRIEF: Scancell bases new facility at Oxford Science Park...
Read moreIN BRIEF: Scancell doses first subject in Covidity phase one trial...
Read moreTRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV...
Read more(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initi...
Read more(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-...
Read moreDIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares...
Read moreTRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook...
Read moreIN BRIEF: Scancell turns once again to Durrant to lead company...
Read more
Last checked at